Quick Answer
ASPEN AEROGELS INC reported Cash and Equivalents of $156.86 million for fiscal year 2025.
ASPEN AEROGELS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $156.86M | -29.0% |
| 2024 | $220.88M | +58.1% |
| 2023 | $139.72M | -50.3% |
| 2022 | $281.33M | +267.5% |
| 2021 | $76.56M | +364.1% |
| 2020 | $16.50M | +354.1% |
| 2019 | $3.63M | +9.2% |
| 2018 | $3.33M | -68.9% |
| 2017 | $10.69M | -40.9% |
| 2016 | $18.09M | -44.9% |
| 2015 | $32.80M | -34.0% |
| 2014 | $49.72M | +3058.8% |
| 2013 | $1.57M | +17.2% |
| 2012 | $1.34M | -88.1% |
| 2011 | $11.24M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $150.72M | +32.8% | -10.1% |
| June 30, 2025 | $167.62M | +83.4% | -12.7% |
| March 31, 2025 | $192.04M | +89.3% | -13.1% |
| December 31, 2024 | $220.88M | +58.1% | +94.6% |
| September 30, 2024 | $113.49M | +19.9% | +24.2% |
| June 30, 2024 | $91.38M | -32.0% | -9.9% |
| March 31, 2024 | $101.46M | -51.1% | -27.4% |
| December 31, 2023 | $139.72M | -50.3% | +47.6% |
- ASPEN AEROGELS INC showed a decrease of -29.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2011–2025 period, ASPEN AEROGELS INC’s cash and equivalents has grown by 1295.4% (from $11.24 million to $156.86 million).
- The most recent figure is from ASPEN AEROGELS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: